Bertil Casslén (Former)
31 – 35 of 35
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- 4
- next »
- 2001
-
Mark
Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer
(
- Contribution to journal › Article
-
Mark
Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1)
(
- Contribution to journal › Article
-
Mark
Paracrine stimulation of capillary endothelial cell migration by endometrial tissue involves epidermal growth factor and is mediated via up-regulation of the urokinase plasminogen activator receptor
(
- Contribution to journal › Article
- 1998
-
Mark
High tissue content of urokinase plasminogen activator (u-PA) is associated with high stromal expression of u-PA mRNA in poorly differentiated serous ovarian carcinoma
(
- Contribution to journal › Article
- 1981
-
Mark
Proteinases and proteinase inhibitors in uterine fluid, with special reference to IUD-users
1981) In Acta obstetricia et gynecologica Scandinavica. Supplement, 0300-8835 ; 98(
- Thesis › Doctoral thesis (compilation)
- « previous
- 1
- 2
- 3
- 4
- next »